Je was op zoek naar: galaktozidaze (Sloveens - Engels)

alfa-galaktozidaze:
alpha-galactosidase:

50 u alfa-galaktozidaze
50 u alpha-galactosidase

100 u alfa-galaktozidaze/kg
100 u alpha-galactosidase/kg

1000 u [1] alfa-galaktozidaze/g,
1000 u [1] alpha-galactosidase/g,

zanjo je značilno pomanjkanje encima α-galaktozidaze.
it is characterised by the deficiency of -galactosidase.

agalzidaza alfa je oblika človeškega encima α-galaktozidaze.
agalsidase alfa is a form of the human enzyme α-galactosidase.

bolniki s fabryjevo boleznijo nimajo dovolj encima alfa- galaktozidaze a.
patients with fabry disease do not have enough of an enzyme, alpha-galactosidase a.

zdravilo replagal je namenjeno nadomeščanju človeškega encima alfa-galaktozidaze a, ki ga primanjkuje osebam s fabryjevo boleznijo.
replagal is designed to replace the human enzyme alpha-galactosidase a, which is lacking in people with fabry disease.

zdravilna učinkovina zdravila galafold, migalastat, se veže na določene nestabilne oblike α- galaktozidaze a in s tem stabilizira encim.
the active substance in galafold, migalastat, attaches to certain unstable forms of alpha-galactosidase a, stabilising the enzyme.

zdravila replagal ne smete dajati sočasno s klorokvinom, amiodaronom, benokvinom ali gentamicinom, saj lahko te snovi zavirajo intracelularno delovanje α-galaktozidaze.
replagal should not be co-administered with chloroquine, amiodarone, benoquin or gentamicin since these substances have the potential to inhibit intra-cellular α-galactosidase activity.

fabrazyme se uporablja kot encimska nadomestna terapija pri fabryjevi bolezni, pri kateri bodisi ni encima α - galaktozidaze, ali pa je količina tega encima manjša od normalne.
fabrazyme is used as enzyme replacement therapy in fabry disease, where the level of α - galactosidase enzyme activity is absent or lower than normal.

fabrazyme vsebuje zdravilno učinkovino agalzidaza beta in se uporablja kot encimska nadomestna terapija pri fabryjevi bolezni, pri kateri bodisi ni encima α-galaktozidaze, ali pa je količina tega encima manjša od normalne.
fabrazyme contains the active substance agalsidase beta and is used as enzyme replacement therapy in fabry disease, where the level of -galactosidase enzyme activity is absent or lower than normal.

kolorimetrična metoda merjenja p-nitrofenola, ki se med delovanjem alfa-galaktozidaze sprosti iz substrata p-nitrofenil-alfa-galaktopiranozida,
colorimetric method measuring p-nitrophenol released by action of alpha-galactosidase from p-nitrophenyl-alpha-galactopyranoside substrate,

evropska agencija za varnost hrane (v nadaljnjem besedilu: agencija) je v svojem mnenju z dne 18. junija 2013 [3] navedla, da pripravek iz alfa-galaktozidaze, ki jo proizvaja saccharomyces cerevisiae (cbs 615.94), in endo-1,4-beta-glukanaze, ki jo proizvaja aspergillus niger (cbs 120604), v predlaganih pogojih uporabe nima škodljivega vpliva na zdravje živali, ljudi ali na okolje ter da je lahko učinkovit pri piščancih za nesnice, kar se lahko ekstrapolira na manjše vrste perutnine za pitanje.
the european food safety authority (‘the authority’) concludes in its opinion of 18 june 2013 [3] that, under the proposed conditions of use, the preparation of alpha-galactosidase produced by saccharomyces cerevisiae (cbs 615.94) and endo-1,4-beta-glucanase produced by aspergillus niger (cbs 120604) does not have an adverse effect on animal health, human health or the environment and it has the potential to be efficacious on chickens reared for laying and that can be extrapolated to minor poultry species for fattening.